Francesca Scionti

Advances in Alport syndrome diagnosis using next-generation sequencing

Rosangela Artuso, Chiara Fallerini, Laura Dosa et al. · European Journal of Human Genetics · 2011 · 82 citations · Full text

Mendelian Disorder, Medicine, Genetics +7

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

Eugenio Morelli, Lavinia Biamonte, Cinzia Federico et al. · Blood · 2018 · 74 citations · Full text

miR-22 suppresses DNA ligase III addiction in multiple myeloma

Daniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio et al. · Leukemia · 2018 · 67 citations · Full text

Tumor Biology, Cell Regulation, Medicine +10

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study

Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio et al. · Journal of Hematology & Oncology · 2023 · 60 citations · Full text

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity

Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta et al. · Liver International · 2019 · 58 citations · Full text